Vijaya Diagnostic Centre Limited (NSE:VIJAYA)
India · Delayed Price · Currency is INR 1,346.10
-14.10 (-1.04%)
Jul 31, 2026, 3:29 PM IST
Vijaya Diagnostic Centre Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 8,142 | 6,814 | 5,478 | 4,592 | 4,624 | |
Revenue Growth | 19.49% | 24.39% | 19.29% | -0.68% | 22.73% |
Cost of Revenue | 946.84 | 1,081 | 863.73 | 764.66 | 847.93 |
Gross Profit | 7,195 | 5,733 | 4,614 | 3,828 | 3,776 |
Selling, General & Admin | 1,307 | 1,235 | 985.79 | 846.63 | 758.93 |
Other Operating Expenses | 2,518 | 1,766 | 1,420 | 1,161 | 979.87 |
Operating Expenses | 4,744 | 3,707 | 2,975 | 2,624 | 2,266 |
Operating Income | 2,451 | 2,026 | 1,639 | 1,203 | 1,510 |
Interest Expense | -332.31 | -245.46 | -219.62 | -194.25 | -152.15 |
Interest & Investment Income | - | 57.63 | 59.73 | 82.8 | 97.99 |
Other Non Operating Income (Expenses) | 207.99 | -19.65 | -16.65 | -13.58 | -9.32 |
EBT Excluding Unusual Items | 2,327 | 1,819 | 1,462 | 1,078 | 1,447 |
Gain (Loss) on Sale of Investments | - | 118.66 | 124.76 | 47.19 | 18.39 |
Gain (Loss) on Sale of Assets | - | 1.31 | 19.52 | 0.86 | 3.98 |
Other Unusual Items | - | -7.04 | -19.95 | 9 | 2.14 |
Pretax Income | 2,327 | 1,932 | 1,587 | 1,135 | 1,474 |
Income Tax Expense | 597.02 | 493.71 | 390.44 | 283.03 | 367.17 |
Earnings From Continuing Operations | 1,730 | 1,438 | 1,196 | 852.07 | 1,107 |
Minority Interest in Earnings | - | -7.18 | -8.12 | -5.75 | -9.87 |
Net Income | 1,730 | 1,431 | 1,188 | 846.32 | 1,097 |
Net Income to Common | 1,730 | 1,431 | 1,188 | 846.32 | 1,097 |
Net Income Growth | 20.90% | 20.41% | 40.40% | -22.84% | 29.83% |
Shares Outstanding (Basic) | 103 | 103 | 102 | 102 | 102 |
Shares Outstanding (Diluted) | 103 | 103 | 103 | 102 | 103 |
Shares Change | 0.24% | 0.26% | 0.03% | -0.08% | 0.57% |
EPS (Basic) | 16.81 | 13.95 | 11.62 | 8.29 | 10.76 |
EPS (Diluted) | 16.79 | 13.92 | 11.59 | 8.26 | 10.69 |
EPS Growth | 20.62% | 20.10% | 40.31% | -22.73% | 29.11% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 878.75 | 1,289 | 953.37 | 397.69 | 356.5 |
Free Cash Flow Per Share | 8.53 | 12.54 | 9.30 | 3.88 | 3.48 |
Dividend Per Share | 2.000 | 2.000 | 1.000 | 1.000 | 1.000 |
Dividend Growth | 0% | 100.00% | 0% | 0% | - |
Gross Margin | 88.37% | 84.14% | 84.23% | 83.35% | 81.66% |
Operating Margin | 30.10% | 29.74% | 29.92% | 26.20% | 32.66% |
Profit Margin | 21.25% | 21.00% | 21.69% | 18.43% | 23.72% |
Free Cash Flow Margin | 10.79% | 18.92% | 17.40% | 8.66% | 7.71% |
EBITDA | 3,369 | 2,411 | 1,930 | 1,581 | 1,846 |
EBITDA Margin | 41.38% | 35.38% | 35.23% | 34.44% | 39.92% |
D&A For EBITDA | 918.24 | 384.32 | 291.19 | 378.31 | 335.58 |
EBIT | 2,451 | 2,026 | 1,639 | 1,203 | 1,510 |
EBIT Margin | 30.10% | 29.74% | 29.92% | 26.20% | 32.66% |
Effective Tax Rate | 25.66% | 25.56% | 24.61% | 24.93% | 24.91% |
Revenue as Reported | 8,350 | 6,997 | 5,686 | 4,734 | 4,752 |
Advertising Expenses | - | 24.83 | 35.51 | 23.78 | 29.17 |